Skip to main content

Cardiff Lexington Corp

corporate_fare Company Profile

Cardiff Lexington Corp

CDIX·OTC·Industrial Applications And Services·CIK 0000811222

Our company is a targeted healthcare holding company that acquires and builds middle-market niche healthcare clinics, primarily in orthopedics, spine care, and pain management. Our acquisition strategy focuses on three complementary pillars: Core Cash Flow, which involves acquiring, optimizing, and managing physician practices; Asset Acquisition, which expands our footprint through ownership of real estate assets like ambulatory surgery centers and orthopedic clinics; and Finance, which retains and manages personal injury practice accounts receivable. We focus on acquiring orthopedic and related modality practices with strong organic growth plans that are materially cash generative. All current revenue is derived from Nova Ortho and Spine, LLC, or Nova, which was acquired on May 31, 2021. Nova operates a group of regional primary specialty and ancillary care facilities across Florida and Georgia. These facilities provide traumatic injury victims with primary care evaluations, interventional pain management, and specialty consultation services, including emergency medical condition, or EMC, assessments. We primarily focus on plaintiff-related care and provide healthcare to uninsured patients who have typically been in an accident and filed a lawsuit. We offer a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. We also own a real estate company, Edge View Properties, Inc., or Edge View, which was acquired on July 16, 2014.

Cardiff Lexington Corp (OTC:CDIX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for CDIX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for CDIX spans 10-Q, 8-K, 424B3, S-1.

Recent high-impact activity:

  • Cardiff Lexington Q3 Loss Widens to $3.2M as Revenue Falls 37% and Going Concern Stands
  • Cardiff Lexington Signs LOI to Acquire Musculoskeletal Platform for Up to $104M
  • Cardiff Lexington Signs $104M LOI to Acquire Multi-State Musculoskeletal Platform
  • Cardiff Lexington Introduces Super-Voting Series A-1 Preferred Stock
  • Cardiff Lexington Q2 2026: Going Concern Warning, Widening Losses, and Toxic Debt

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$11.54M
Net Income
-$5.51M
Gross Profit
$7.21M
Operating Income
$1.1M
Cash & Equivalents
$318.54K
Debt / Equity
0.00×
Net Margin
-47.7%
Shares Outstanding
13.7M sh
Source: 10-K · filed 2026-03-10 · accession 0001683168-26-001639

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 555 shares in CDIX as of the October 30, 2026 settlement, a 5.6% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 64.4% of CDIX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)555 shares as of October 30, 2026
Change vs prior period▼ 5.6%
Days to cover1.00 at avg daily volume of 423,795
Daily short volume (FINRA facilities)64.4% of 31,046 shares on November 20, 2026
5-day average short volume8.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for CDIX, detected from its recent SEC filings · based on capital-structure filings through 2026-06-23.

1 shelf registration

Equity Purchase Facility Finalized · Significant Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$0.005 -34.21% today
52-week range · as of 2026-11-10 $0.005 – $22.5
Market cap
$167.56K
Volume
41K (0.2× avg)
3-mo avg 223.2K
Live data · 2026-11-22 11:12 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CDIX - Latest Insights

CDIX
Nov 10, 2026, 12:29 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0119
Real-time Price: $0.0050 info
Change: -$0.0069 (-58%) info
Market Cap: $167.559K info
CDIX
Sep 24, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.600
Real-time Price: $0.0050 info
Change: -$0.595 (-99%) info
Market Cap: $167.559K info
CDIX
Sep 24, 2026, 7:59 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.600
Real-time Price: $0.0050 info
Change: -$0.595 (-99%) info
Market Cap: $167.559K info
CDIX
Sep 04, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.1162
Real-time Price: $0.0050 info
Change: -$0.1112 (-96%) info
Market Cap: $167.559K info
CDIX
Aug 12, 2026, 8:47 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.600
Real-time Price: $0.0050 info
Change: -$0.595 (-99%) info
Market Cap: $167.559K info
CDIX
Jun 23, 2026, 3:21 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.80
Real-time Price: $0.0050 info
Change: -$1.80 (-100%) info
Market Cap: $167.559K info
CDIX
Jun 11, 2026, 4:36 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $1.72
Real-time Price: $0.0050 info
Change: -$1.71 (-100%) info
Market Cap: $167.559K info
CDIX
Jun 11, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.72
Real-time Price: $0.0050 info
Change: -$1.71 (-100%) info
Market Cap: $167.559K info
CDIX
Jun 11, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.72
Real-time Price: $0.0050 info
Change: -$1.71 (-100%) info
Market Cap: $167.559K info
CDIX
May 13, 2026, 1:37 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.24
Real-time Price: $0.0050 info
Change: -$2.24 (-100%) info
Market Cap: $167.559K info
CDIX
Mar 10, 2026, 3:06 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $3.10
Real-time Price: $0.0050 info
Change: -$3.10 (-100%) info
Market Cap: $167.559K info
CDIX
Feb 05, 2026, 3:19 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $0.0050 info
Change: -$1.30 (-100%) info
Market Cap: $167.559K info
CDIX
Feb 03, 2026, 3:59 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.30
Real-time Price: $0.0050 info
Change: -$1.30 (-100%) info
Market Cap: $167.559K info
CDIX
Jan 20, 2026, 4:59 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $0.0050 info
Change: -$1.30 (-100%) info
Market Cap: $167.559K info
CDIX
Jan 05, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $0.0050 info
Change: Reverse Stock Split info
Market Cap: $167.559K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets